...
首页> 外文期刊>Scientific reports. >Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease
【24h】

Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease

机译:翻译后修改作为血红蛋白氧化在镰状细胞病中血红蛋白氧化诱导的细胞应激的反应

获取原文

摘要

Intracellular oxidative stress and oxidative modification of sickle hemoglobin (HbS) play a role in sickle cell disease (SCD) pathogenesis. Recently, we reported that Hb-dependent oxidative stress induced post-translational modifications (PTMs) of Hb and red blood cell (RBC) membrane proteins of transgenic SCD mice. To identify the mechanistic basis of these protein modifications, we followed in vitro oxidative changes occurring in intracellular Hb obtained from RBCs and RBC-derived microparticles (MPs) from the blood of 23 SCD patients (HbSS) of which 11 were on, and 12, off hydroxyurea (HU) treatment, and 5 ethnic matched controls. We used mass spectrometry-based proteomics to characterize these oxidative PTMs on a cross-sectional group of these patients (n?=?4) and a separate subgroup of patients (n?=?2) studied prior to initiation and during HU treatment. Collectively, these data indicated that band-3 and its interaction network involved in MPs formation exhibited more protein phosphorylation and ubiquitination in SCD patients than in controls. HU treatment reversed these oxidative PTMs back to level observed in controls. These PTMs were also confirmed using orthogonal immunoprecipitation experiments. Moreover, we observed specific markers reflective of oxidative stress, including irreversible oxidation of βCys93 and ubiquitination of Hb βLys145 (and βLys96). Overall, these studies strongly suggest that extensive erythrocyte membrane protein phosphorylation and ubiquitination are involved in SCD pathogenesis and provide further insight into the multifaceted effects of HU treatment.
机译:镰状血红蛋白(HBS)的细胞内氧化应激和氧化改性在镰状细胞疾病(SCD)发病机制中起作用。最近,我们报道了Hb依赖性氧化应激诱导转基因SCD小鼠的HB和红细胞(RBC)膜蛋白的翻译后修饰(PTM)。为了鉴定这些蛋白质修饰的机械基础,我们遵循从RBCS和RBC衍生的微粒(MPS)的细胞内HB中发生的体外氧化变化,其中来自23例SCD患者(HBSS)的血液,其中11名,12, OFF羟基脲(HU)治疗和5种族匹配对照。我们使用基于质谱的蛋白质组学来表征这些患者的横截面积上的这些氧化PTMS(n?=Δ4)和在开始之前和Hu治疗期间研究的患者的单独子组(n?=Δ2)。总的来说,这些数据表明,涉及MPS形成中涉及的带3及其相互作用网络在SCD患者中表现出更多的蛋白质磷酸化和ubiquitation,而不是对照。 Hu治疗将这些氧化PTMS逆转回到对照中观察到的水平。还使用正交免疫沉淀实验证实了这些PTM。此外,我们观察了反映氧化应激的特异性标记,包括βCys93的不可逆氧化和Hbβlys145(和β1106)的泛素。总体而言,这些研究强烈表明,广泛的红细胞膜蛋白磷酸化和普遍术涉及SCD发病机制,并进一步了解Hu治疗的多方面效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号